Evidence map›Paper›PMID 32932875›Full record

ArticleMicroorganisms2020

Phylogenetic Assignment of the Fungicolous

Kevin Becker, Christopher Lambert, Jörg Wieschhaus, Marc Stadler

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Maleimide-substituted 1,4-naphthoquinone flaviolin mimetic (FMMedical oncology (Northwood, London, England) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Novel secondary metabolite from a new species ofCurrent research in microbial sciences · 2025
    Article
  6. Article
  7. Mycology · 2025
    Article
  8. Article
  9. Eight novel cave fungi in Thailand's Satun Geopark.Fungal systematics and evolution · 2023
    Article
  10. Article
  11. Three New Species ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Resolution of theJournal of fungi (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin BeckerDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany.ORCID 0000-0002-6490-4100
Christopher LambertDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany.ORCID 0000-0002-1899-8214
Jörg WieschhausDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany.
Marc StadlerDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany.ORCID 0000-0002-7284-8671
German Center for Infection Research · DEHelmholtz Centre for Infection Research · DE

Funding

Deutsche Forschungsgemeinschaft SPP1991 TaxonOmics
6 · The paper itself

Abstract

The ascomycete

Indexed as

Ascomycotachromatographymultigene phylogenynaphthoquinonestaxonomyXylariales

Identifiers

PMID32932875
PMCPMC7565716
OpenAlexW3085154881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.